Drug Evaluation Committee The 103rd Annual Meeting of the Clinical Evaluation Committee (Part 2) - The Near Horizon of Drug Development
Feb 21, 2020
- 0_Part 2 Program (164KB)
- 1_State of the art of clinical biomarker strategy for realization of personalized medicine (3MB)
- 2_Welcome to the Pediatric World (2.6MB)
- 3_Utilization of Medical Big Data and Real World Data for Drug Development (747KB)
- 4_Patient Voice in Drug Development Takes Root in Japan (1.7MB)